FDA Adverse Event Injury Summary report: N

BARRICAID ACD

MDR report key: 19932752 · Received August 7, 2024

Report

Report Number
3006232063-2024-00030
Event Type
Injury
Date Received
August 7, 2024
Date of Event
July 9, 2024
Report Date
August 7, 2024
Manufacturer
INTRINSIC THERAPEUTICS, INC
Product Code
QES
UDI-DI
M906BARA810MM0
PMA / PMN Number
P160050
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE DESCRIPTION OF THE EVENTS DETAILED IN THIS MDR REPRESENT INTRINSIC THERAPEUTIC'S UNDERSTANDING AT THE TIME OF SUBMISSION. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION ANOTHER FOLLOW-UP WILL BE COMPLETED. INTRINSIC THERAPEUTICS WILL CONTINUE TO MONITOR FOR UPDATES/TRENDS.

Description of Event or Problem · 0

PHYSICIAN FIRST CONTACTED INTRINSIC REPRESENTATIVE ON JULY 09TH TO STATE THERE WAS AN INFLAMMATORY RESPONSE TO THE IMPLANT. ON (B)(6) 2024 THE SITE WAS ASPIRATED AND CULTURED AND NO CSF LEAK OR BACTERIAL CULTURES WERE OBSERVED. A FOLLOW-UP SURGERY WAS PERFORMED ON (B)(6) 2024 WHERE THE BARRICAID IMPLANT WAS REMOVED AND THERE WAS A CONFIRMED SEROMA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
518266 BARRICAID ACD BARRICAID QES INTRINSIC THERAPEUTICS, INC BAR-A8-10MM 08242308 M906BARA810MM0

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other